AzTrials
AzTrials

Muscle HypertrophySLMLNCT06666127

The Effect of Peak Force At Long and Short Muscle Lengths and the Impact on Muscle Growth and Strength

A study testing LONG and SHORT Resistance Training, Maximal Isotonic Strength Testing (1RM) and Isokinetic Strength Testing in people with Muscle Hypertrophy and Muscular Strength, run by University of British Columbia at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn the effect of applying peak force/resistance to skeletal muscles during resistance exercise training in young and healthy adults. Participants will undergo two types of resistance training conditions that are randomly assigned to the left arm and leg and the right arm and… Read more about this study

Who is it for?
Ages 19 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Muscle Hypertrophy, Muscular Strength
What is being tested?
LONG and SHORT Resistance Training, Maximal Isotonic Strength Testing (1RM) and Isokinetic Strength Testing
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteCanada
Study dates
1 Dec 2024to 30 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Any sex
  • Able to understand and communicate in English
  • 19-30 years of age
  • All "No" answers on the CSEP Get Active questionnaire or doctors' approval to participate
  • Untrained participants: no structured resistance training over the past 12-months (i.e. > 2 hours per week of structured/periodized training)

Who cannot join

  • BMI lower than 18 or greater than 30
  • Difficulty to understand and communicate in English
  • Current use of cigarettes or other nicotine devices
  • Any major uncontrolled cardiovascular, muscular, metabolic, and/or neurological disorders
  • Any medical condition impacting the ability to participate in maximal exercise
  • Type one or type two diabetes
Show all 12Show fewer
  • Diagnosis of cancer or undergoing cancer treatment in the past 12 months
  • Drug therapy with any drugs that alter skeletal muscle metabolism (i.e., Metformin, Benzodiazepines)
  • Omega-3 (EPA, DHA, fish oil) supplementation within the previous 6 weeks
  • Implants containing ferrous metal
  • Surgery or tattoos (including tattooed eyeliner) in the last 6 weeks
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of British Columbia

    Vancouver, British Columbia, V6T 1Z4

Other trials in Canada

About this study

Official title: Determining the Effect of Muscle Length At Peak Force on Resistance Training Induced Hypertrophy

The goal of this clinical trial is to learn the effect of applying peak force/resistance to skeletal muscles during resistance exercise training in young and healthy adults. Participants will undergo two types of resistance training conditions that are randomly assigned to the left arm and leg and the right arm and leg. The LONG condition refers to Prime Fitness machines set to setting number '3' which applies peak force at a long muscle length. The SHORT condition refers to Prime Fitness machines set to setting number '2' which applies peak force at a short muscle length.

The main questions the trial aims to answer are:

Read more
  1. Does applying peak force at a longer or shorter muscle length during resistance exercise training result in greater muscle growth?
  2. Does applying peak force at a longer or shorter muscle length during resistance exercise training result in greater muscle growth?

We hypothesize that:

  1. LONG will induce greater hypertrophy compared to SHORT conditions
  2. LONG will result in greater increases in 1RM strength compared to SHORT
  3. LONG and SHORT training will result in angle specific increases in isokinetic strength
  4. Muscle oxygenation will decline to a greater degree during LONG compared to SHORT exercise and this will be maintained between weeks 1 and 12 of training

The investigators will compare the change in muscle volume and muscular strength between the LONG and SHORT training conditions, which each participant will have the left arm and leg as well as the right arm and leg randomly assigned to either exclusively LONG or SHORT conditions.

Participants will:

  • Resistance train the left and right arm and leg with two separate conditions; LONG and SHORT for 12 weeks, with the first and last weeks dedicated to only strength testing (Isotonic and Isokinetic) and measuring muscle volume via magnetic resonance imaging (MRI)
  • Visit the gym for resistance training 2 times per week
  • Visit the UBC MRI Research Facility in weeks 1 and 12 for MRI of muscle volume
Read the detailed description

Statistical Analysis:

Null Hypothesis Significance Testing (NHST) will be used to measure differences in hypertrophy, differences in 1RM strength, Isokinetic strength and muscle oxygenation between LONG and SHORT conditions.

It is anticipated that this study will require at least 20 participants to be screened and registered into the trial. Data will be analyzed on the basis that all participants will be included in the analysis. Participants who drop out (withdraw from treatment) will be followed up with to collect all available data and will not be replaced. Missing data will be assumed missing at random.

Sample Size Calculation:

Based on the effect size reported by Maeo et al. (2023) for difference in triceps brachia long head hypertrophy between training performed in the lengthened compared to shortened position using a within participant design, (d=0.61) a sample size of 20 participants was calculated to achieve an a priori power of 90%.

Being tested
LONG and SHORT Resistance Training, Maximal Isotonic Strength Testing (1RM), Isokinetic Strength Testing, Muscle Oxygenation
Keywords
Muscle Hypertrophy, Muscular Strength, Long Muscle Lengths, Peak Force, Length-Tension Relationship, Range of Motion, Neuromechanical Matching, Resistance Training, Muscle Oxygenation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • LONG and SHORT Resistance TrainingOther

    One side of the body will be randomly assigned to perform exercises in position 3 (LONG) with the other randomly assigned to position 2 (SHORT) of Prime Fitness horizontal shoulder adduction, horizontal shoulder abduction, shoulder abduction and hip extension. Each exercise will include 1 warm up set at 50% 1RM followed by 4-5 sets of 8-12 repetitions per limb. 2 minutes of rest between sets on the same side of body will be administered as the participant will alternate between the right and left limb. The left and right side limbs will alternate each session in which one starts each exercise, resulting in 10 training sessions each where the left and right limbs starts first on each exercise. All sets will be performed to momentary failure. A Dynamic Double Progression will be employed to ensure intensity is maintained.

  • Maximal Isotonic Strength Testing (1RM)Other

    Each limb will perform a 1RM strength test with each Prime Fitness machine training horizontal shoulder adduction, horizontal shoulder abduction, shoulder abduction and hip extension respectively. Each machine will be set to position 1 (maximal load in mid-range). Testing will occur in weeks 1 and 12 of the study with the non-dominant arm and leg tested before the dominant arm and leg in each exercise. Participants self-selects first warm up set with a weight that is performed between 6-10 repetitions on both limbs. Rest for 1 minute between limbs and subsequent set. A weight is then selected by research staff to perform 3 repetitions with based on previous set. Load is now increased until 1RM is achieved. Rest periods should remain at least 1 minute alternating between limbs, with 1RM being complete within 3-5 attempts. Participant will rest 2-5 minutes before starting testing on the next exercise. Repeat for all exercises. Use pre testing data to inform 1RM attempts for post testing.

  • Isokinetic Strength TestingOther

    Participants will engage in isokinetic strength testing on the isokinetic dynamometer (Biodex) in weeks 1 and 12 for each of the four movements: Horizontal shoulder adduction, horizontal shoulder abduction, shoulder abduction and hip extension. Participants will perform each movement unilaterally. Participants will start with the non-dominant arm and leg for each movement. Each movement will be tested through A maximal active range of motion. Participants will complete 10 sub-maximal repetitions to allow familiarization each movement. After a 2-minute rest, participants will complete 3 maximal concentric and eccentric repetitions with 30 seconds rest at 30 degrees per second before the Biodex is reset for the next movement.

  • Muscle OxygenationOther

    During the first and last LONG and SHORT training session (visit 5 and visit 24), A near infrared spectroscopy sensor (NIRS device) (Trainred) will be affixed to the muscle belly of the deltoid during the lateral raise exercise to measure muscle oxygenation.

Study groups in NCT06666127
Study groupRoleWhat they receive
SHORT and LONG Training ProtocolExperimentalUsing a within subject design, participants will have the arms and legs from both left and right side of the body (divided by sagittal plane) randomly assigned to either LONG or SHORT conditions. Participants will then engage in maximal strength testing on Prime Fitness machines (1RM) as well as isokinetic strength testing (Biodex) in weeks 1 and 12. Participants will engage in the LONG and SHORT training sessions for 10 weeks in duration from week 2 until week 11.
Receives: Other: LONG and SHORT Resistance Training; Other: Maximal Isotonic Strength Testing (1RM); Other: Isokinetic Strength Testing; Other: Muscle Oxygenation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Muscle Volume

    Muscle volume of the pectoralis major, deltoid and gluteus maximus muscle will be measured by cross sectional area (CSA) via Magnetic Resonance Imaging (MRI). The entire muscle length will be imaged and images at 25%, 50% and 75% of the entire muscle length will be analyzed to calculate CSA and any regional differences in hypertrophy.

    Measured: From enrolment to the end of the intervention at 12 weeks

Secondary outcomes (3)
  1. Isotonic Strength testing

    Isotonic strength testing will compare the magnitude of gains in isotonic strength via a one repetition maximum test (1RM) which is the maximum weight lifted for 1 repetition. Isotonic strength will be measured using the Prime Fitness Machines used in the LONG and SHORT conditions for four different movements. Single arm shoulder horizontal adduction (Prime Fitness Chest Fly), single arm shoulder horizontal abduction (Prime Fitness Rear Deltoid Fly), single arm shoulder abduction (Prime Fitness Lateral Raise) and single leg hip extension (Prime Fitness Multi-Hip) 1RM (maximum weight lifted for 1 repetition).

    Measured: Initial testing in week 1 and final testing in week 12

  2. Isokinetic Strength Testing

    Isokinetic Strength Testing: Compare the magnitude of gains in isokinetic strength in the LONG and SHORT conditions for four different movements.

    Single arm shoulder horizontal adduction, shoulder abduction and single leg hip extension measured on an isokinetic dynamometer (Biodex) at long, moderate and short muscle lengths for both the concentric and eccentric contraction phases.

    Measured: Initial testing in week 1 and final testing in week 12

  3. Muscle Oxygenation

    To compare muscle oxygenation of the deltoid between LONG and SHORT conditions during the first and last LONG and SHORT training sessions. Muscle oxygenation will be measured using a Near Infra-Red Spectroscopy (NIRS) device that will be placed on the participants shoulder during deltoid training.

    Measured: Week 2 and week 11.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Oct 2024
  2. Study start1 Dec 2024 (estimated)
  3. Primary completion1 May 2025 (estimated)
  4. Study completion30 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Within-Subject Design: Each participant will have the left arm and leg as well as the right arm and leg randomly assigned to the LONG or SHORT condition. Each participant will perform both conditions, exclusively for the left or right sided limbs. This helps to control for genetics, nutrition, recovery, stress management and training history as each participant acts as a self-control group as well as both experimental conditions.
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06666127
Sponsor's protocol ID
H24-01989
Acronym
SLML
Status last verified
Oct 2024
First submitted
22 Oct 2024
Last updated
8 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Maeo S, Wu Y, Huang M, Sakurai H, Kusagawa Y, Sugiyama T, Kanehisa H, Isaka T. Triceps brachii hypertrophy is substantially greater after elbow extension training performed in the overhead versus neutral arm position. Eur J Sport Sci. 2023 Jul;23(7):1240-1250. doi: 10.1080/17461391.2022.2100279. Epub 2022 Aug 11.

    PubMed 35819335

Questions about this trial

What is this clinical trial studying?

A study testing LONG and SHORT Resistance Training, Maximal Isotonic Strength Testing (1RM) and Isokinetic Strength Testing in people with Muscle Hypertrophy and Muscular Strength, run by University of British Columbia at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Muscle Volume (time frame: From enrolment to the end of the intervention at 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06666127, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in